Source | hl7.fhir.uv.pddi#current:Potential Drug-Drug Interaction (PDDI) CDS IG : STU1 Ballot 2 (v4.0.1) |
resourceType | ValueSet |
id | valueset-cyclosporine-exclude |
canonical | http://hl7.org/fhir/uv/pddi/ValueSet/valueset-cyclosporine-exclude |
version | 1.0.0-ballot |
status | draft |
publisher | HL7 Clinical Decision Support Workgroup |
name | Valueset_cyclosporine_exclude |
title | Exclude cyclosporine Medications Value Set |
date | 2018-07-02 |
experimental | true |
description | ValueSet containing drug identifiers to exclude. Criteria is explicitly stating ophthalmic formulations. |
copyright | (copyright expectations unknown) |
jurisdictions | uv |
Usages | (none) |
http://www.nlm.nih.gov/research/umls/rxnorm
Code | Display |
1093178 | Cyclosporine 0.002 MG/MG Ophthalmic Ointment [Optimmune] |
402092 | Cyclosporine 0.5 MG/ML Ophthalmic Suspension [Restasis] |
1093177 | Cyclosporine Ophthalmic Ointment [Optimmune] |
402330 | Cyclosporine Ophthalmic Suspension [Restasis] |
1093174 | Cyclosporine 0.002 MG/MG Ophthalmic Ointment |
351291 | Cyclosporine 0.5 MG/ML Ophthalmic Suspension |
1093173 | Cyclosporine Ophthalmic Ointment |
378766 | Cyclosporine Ophthalmic Suspension |
1156187 | Cyclosporine Ophthalmic Product |
1182342 | Optimmune Ophthalmic Product |
1182527 | Restasis Ophthalmic Product |
Produced 06 Apr 2023